Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hdac3 regulates lymphovenous and lymphatic valve formation
Harish P. Janardhan, … , John F. Keaney Jr., Chinmay M. Trivedi
Harish P. Janardhan, … , John F. Keaney Jr., Chinmay M. Trivedi
Published October 16, 2017
Citation Information: J Clin Invest. 2017;127(11):4193-4206. https://doi.org/10.1172/JCI92852.
View: Text | PDF
Research Article Development Vascular biology

Hdac3 regulates lymphovenous and lymphatic valve formation

  • Text
  • PDF
Abstract

Lymphedema, the most common lymphatic anomaly, involves defective lymphatic valve development; yet the epigenetic modifiers underlying lymphatic valve morphogenesis remain elusive. Here, we showed that during mouse development, the histone-modifying enzyme histone deacetylase 3 (Hdac3) regulates the formation of both lymphovenous valves, which maintain the separation of the blood and lymphatic vascular systems, and the lymphatic valves. Endothelium-specific ablation of Hdac3 in mice led to blood-filled lymphatic vessels, edema, defective lymphovenous valve morphogenesis, improper lymphatic drainage, defective lymphatic valve maturation, and complete lethality. Hdac3-deficient lymphovenous valves and lymphatic vessels exhibited reduced expression of the transcription factor Gata2 and its target genes. In response to oscillatory shear stress, the transcription factors Tal1, Gata2, and Ets1/2 physically interacted with and recruited Hdac3 to the evolutionarily conserved E-box–GATA–ETS composite element of a Gata2 intragenic enhancer. In turn, Hdac3 recruited histone acetyltransferase Ep300 to form an enhanceosome complex that promoted Gata2 expression. Together, these results identify Hdac3 as a key epigenetic modifier that maintains blood-lymph separation and integrates both extrinsic forces and intrinsic cues to regulate lymphatic valve development.

Authors

Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi

×

Figure 3

Hdac3 deficiency causes impaired lymphatic drainage and anomalous lymphatic valve development in mesenteric lymphatic vessels.

Options: View larger image (or click on image) Download as PowerPoint
Hdac3 deficiency causes impaired lymphatic drainage and anomalous lympha...
(A and B) Evans blue dye injection into the left hind paw (A and B, white arrows) of P5 Hdac3Cdh5KO mice showed reflux (retrograde flow) into the tail, right hind limb, and abdomen (A and B, red arrows) compared with an absence of reflux in the control mice (black arrows). Original magnification ×2.5. (C and D) P5 Hdac3Cdh5KO mice showed Evans blue dye reflux (red arrows) into dermal lymph vessels and mesenteric lymph nodes compared with control mice (dotted line, black arrows). Original magnification ×3. (E) Control P5 mice showed normal unidirectional cephalad drainage restricted to the thoracic duct (black arrow). Hdac3Cdh5KO mice exhibited reflux into the intercostal lymphatics lateral to the thoracic duct in the thoracoepigastric region (red arrows) and reduced drainage into the thoracic duct (green arrow). (F) Coimmunofluorescence staining for Lyve1 (green) and smooth muscle actin (SMA) (red) showed abnormal smooth muscle recruitment (white arrows) to blood-filled dermal lymphatic capillaries in P6 Hdac3Cdh5KO mice compared with controls. (G) Quantitation of lymphatic valve territories in E17.5 Hdac3Lyve1KO mesenteric lymphatic vessels. The P value was determined by unpaired Student’s t test. (H–J) Whole-mount coimmunofluorescence staining of Hdac3Lyve1KO (H and I) and Hdac3Cdh5KO (J) mesenteric lymphatic vessels showed a lack of Prox1-expressing (red) lymphatic valves in Pecam1+ (green) lymphatic vessels (yellow arrows) compared with controls (white arrows). (K and L) Whole-mount coimmunofluorescence staining of Hdac3Lyve1KO (K) and Hdac3Cdh5KO (L) mesenteric lymphatic vessels showed a lack of Itga9-expressing (green) lymphatic valves in Prox1+ (red) lymphatic vessels (yellow arrows) compared with controls (white arrows). (M and N) Whole-mount coimmunofluorescence staining of Hdac3Lyve1KO (M) and Hdac3Cdh5KO (N) mesenteric lymphatic vessels showed excessive SMA (red) coverage (yellow arrows) compared with controls (white arrows). Vegfr3 (green) was used as a lymphatic vessel marker. Data represent the mean ± SEM and are representative of 3 independent experiments. Sub-stacks of Z-stack images are presented in H–N. Scale bars: 100 μm (F) and 1 μm (H–N). See also Supplemental Figure 6.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts